PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

126 hedge funds and large institutions have $518M invested in Progenics Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 17 closing their positions.

Holders
126
Holders Change
+11
Holders Change %
+9.57%
% of All Funds
3.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
31
Increased
36
Reduced
44
Closed
17
Calls
$2.19M
Puts
$1.05M
Net Calls
+$1.14M
Net Calls Change
+$693K
Name Holding Trade Value Shares
Change
Shares
Change %
KCM
126
Kennedy Capital Management
Missouri
-$3.25M -513,375 Closed
ACP
127
Acuta Capital Partners
California
-$2.74M -432,370 Closed
NC
128
Nexthera Capital
New York
-$2.22M -350,000 Closed
HP
129
HealthInvest Partners
Sweden
-$1.77M -280,000 Closed
EI
130
EAM Investors
California
-$917K -144,902 Closed
SC
131
Searle & Co
Connecticut
-$726K -105,000 Closed
HCM
132
Highbridge Capital Management
New York
-$402K -63,548 Closed
ARTA
133
A.R.T. Advisors
New York
-$225K -35,700 Closed
TSS
134
Two Sigma Securities
New York
-$109K -17,172 Closed
GI
135
GAMCO Investors
Connecticut
-$108K -17,000 Closed
SSA
136
Schonfeld Strategic Advisors
New York
-$97K -15,374 Closed
PHK
137
Point72 Hong Kong
Hong Kong
-$73K -11,500 Closed
AIM
138
Alambic Investment Management
California
-$69K -10,900 Closed
Wolverine Trading
139
Wolverine Trading
Illinois
-$61K -10,668 Closed
FP
140
Foundry Partners
Minnesota
-$67K -10,600 Closed
SIM
141
Strategic Investment Management
Virginia
-$63K -10,013 Closed
CSS
142
Cubist Systematic Strategies
Connecticut
-$12K -1,937 Closed